Pierre Fayolle

Mr. Pierre Fayolle

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Xavier Maximin LE GUILLOU HORNXavier Maximin LE GUILLOU HORN
Xavier Maximin LE GUILLOU HORN
FLFrançois Lecellier
François Lecellier
CGClément Giraud
Clément Giraud
MNMathieu Naudin
Mathieu Naudin
PFPierre Fayolle
Pierre Fayolle
Rémy GuillevinRémy Guillevin
Rémy Guillevin
Background: Gliomas, including the most severe form known as glioblastomas, are primary brain tumors arising from glial cells, with significant impact on adults, particularly men aged 45 to 70. Recent advancements in the WHO (World Health Organization) classification now correlate genetic markers with glioma phenotypes, enhancing diagnostic precision and therapeutic strategies. Aims and Methods: This scoping review aims to evaluate the current state of deep learning (DL) applications in the genetic characterization of adult gliomas, addressing the potential of these technologies for a reliable virtual biopsy. Results: We reviewed 17 studies, analyzing the evolution of DL algorithms from fully convolutional networks to more advanced architectures (ResNet and DenseNet). The methods involved various validation techniques, including k-fold cross-validation and external dataset validation. Conclusions: Our findings highlight significant variability in reported performance, largely due to small, homogeneous datasets and inconsistent validation methods. Despite promising results, particularly in predicting individual genetic traits, the lack of robust external validation limits the generalizability of these models. Future efforts should focus on developing larger, more diverse datasets and integrating multidisciplinary collaboration to enhance model reliability. This review underscores the potential of DL in advancing glioma characterization, paving the way for more precise, non-invasive diagnostic tools. The development of a robust algorithm capable of predicting the somatic genetics of gliomas or glioblastomas could accelerate the diagnostic process and inform therapeutic decisions more quickly, while maintaining the same level of accuracy as the traditional diagnostic pathway, which involves invasive tumor biopsies.

1 April 2026
Verified
Book Chapter
Closed access
PDF file
PFPierre Fayolle
Pierre Fayolle
ABAlexandre Bône
Alexandre Bône
NDNoëlie Debs
Noëlie Debs
PRPhilippe Robert
Philippe Robert
PBPascal Bourdon
Pascal Bourdon
DHDavid Helbert
David Helbert